These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7217026)

  • 1. Thiothixene plasma levels and clinical response in acute schizophrenia.
    Reifler BV; Ward N; Davis CM; Freidel RO
    J Clin Psychiatry; 1981 May; 42(5):207-11. PubMed ID: 7217026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.
    Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of thiothixene plasma levels.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychopharmacol; 1984 Jun; 4(3):155-7. PubMed ID: 6736276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level monitoring of thiothixene in schizophrenia: acute single-dose levels at fixed doses.
    Yesavage JA; Becker J; Werner PD; Mills MJ; Holman CA; Cohn R
    Am J Psychiatry; 1982 Feb; 139(2):174-8. PubMed ID: 7055286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels.
    Yesavage JA
    Biol Psychiatry; 1982 Nov; 17(11):1331-7. PubMed ID: 7150681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients.
    Ahmad SH; Hasan KZ
    J Pak Med Assoc; 1977 Apr; 27(4):313-6. PubMed ID: 411951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary attempt to relate individual differences in EEG test dose response to clinical effect.
    May PR; Itil T; Van Putten T; Lee MA; Yale C
    Biol Psychiatry; 1982 May; 17(5):599-603. PubMed ID: 7093395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene.
    Kim DY; Hollister LE
    J Clin Psychopharmacol; 1984 Feb; 4(1):32-5. PubMed ID: 6693581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays.
    Yesavage JA; Holman CA; Cohn R; Lombrozo L
    Arch Gen Psychiatry; 1983 Mar; 40(3):301-4. PubMed ID: 6830409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma concentrations of thiothixene and clinical response in treatment-resistant schizophrenics.
    Hollister LE; Lombrozo L; Huang CC
    Int Clin Psychopharmacol; 1987 Jan; 2(1):77-82. PubMed ID: 3312399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia and steady-state serum levels of thiothixene.
    Yesavage JA; Tanke ED; Sheikh JI
    Arch Gen Psychiatry; 1987 Oct; 44(10):913-5. PubMed ID: 2889439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene.
    Huang CC; Gerhardstein RP; Kim DY; Hollister L
    Int Clin Psychopharmacol; 1987 Jan; 2(1):69-75. PubMed ID: 3312398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of thiothixene by radioreceptor assay: clinical usefulness.
    Van Putten T; May PR; Marder SR; Wilkins JN; Rosenberg BJ
    Psychopharmacology (Berl); 1983; 79(1):40-4. PubMed ID: 6403963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol: therapeutic window in schizophrenia.
    Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E
    J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.